SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Hospitals are participating in fewer health insurance networks in 2016 New research suggests it may be part of normal market evolution

Britain's junior doctors striking in contract dispute Doctors say government rejected 'fair' offer

Against the odds, Princeton Baptist cardiologist saves patient's life First-of-its-kind 20 hour procedure conducted on massive aneurysm

Optical Coherence Tomography scanner a boon to basal-cell diagnosis VivoSight OCT may lead to a future with fewer biopsies

Philips and Validic aim to combine fitness data with the EHR Adding medical value to consumer wearables

With Avicenna, IBM Watson Health interprets radiology images Commercialization preparations are just beginning

Are low dose radiation concerns based on bad science? Loyola research team thinks so Examining the harmful side of dose preoccupation

Toshiba to sell non-imaging health care business in addition to Medical Systems division Stock in the company has hit 35-year low

MR illuminates link between multiple sclerosis, inferior ability to taste MS brain lesions inversely correlate with taste capability: report

Pacemaker and ICD battery life needs to be extended to last 25 years Replacing batteries can lead to life-threatening infections

Imaging biomarkers enable early diagnosis
and assessment of treatment

Siemens Opens Research Facility for Molecular Imaging Biomarkers

by Barbara Kram , Editor
LOS ANGELES and HOFFMAN ESTATES, Ill. - Siemens Medical Solutions has opened a new state-of-the-art research facility dedicated exclusively to the development of molecular imaging biomarkers, which will become in vivo diagnostic tools for identifying debilitating diseases such as cancer, and neurological diseases at their earliest stages.

The opening of the Siemens Medical Solutions Molecular Imaging (MI) Biomarker Research facility is the latest step for the company in becoming the world's first full-service diagnostics company, integrating in vivo and in vitro imaging diagnostics capabilities. Siemens recently launched Siemens Medical Solutions Diagnostics as the in vitro complement to the portfolio on the heels of acquisitions of Bayer Diagnostics and Los Angeles-based Diagnostic Products Corporation.

Story Continues Below Advertisement

Ventilators Plus-The Easy #1 Choice In Ventilator Sales, Rentals & Support.

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well we BUY,SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7.Call 888-889-2992



"Molecular medicine is heralding a new era in diagnostic capabilities that could change the lives of millions of Americans - and Siemens is helping lead the field out of the research lab and into practical use," said Michael Reitermann, president, Molecular Imaging division, Siemens Medical Solutions. "Advancing this field brings with it the promise of personalized therapeutics, which would not only improve the efficiency of health care, but most importantly, would also improve the quality of health care for patients."

Siemens Medical Solutions MI Biomarker Research facility will be dedicated solely to the discovery and development of new imaging biomarkers to spur the growth of in vivo molecular diagnostics. Imaging biomarkers are molecules that are specifically designed to seek out disease indicators that may appear in individual cells or tissue in the organism and that may provide early warning signs of disease. Once these imaging biomarkers bind to the diseased cells or tissues, they cause them to "light up" when scanned using PET (Positron Emission Tomography, CT(Computed Tomography) or SPECT(Single-Photon Emission Computed Tomography).

Imaging biomarkers not only enable early diagnosis, but also allow the measurement of how well certain therapies, such as prescription drugs, chemotherapy and radiation therapy, may be working by measuring the impact of treatments on the disease indicators. This may aid the development of new therapies, and enable clinicians to non-invasively assess therapeutic success and quickly adjust therapeutic approaches to arrive at optimum outcomes.

The new Siemens' facility will be led by Hartmuth Kolb, Ph.D, vice president, Siemens Medical Solutions MI Biomarker Research. The facility will house scientists, dedicated to the discovery of new imaging agents and their clinical development, with the goal of bringing several new agents to the market over the next 5 - 10 years. Research and development efforts conducted at the facility will focus largely on oncology and neurology, and also include other areas such as inflammation and microfluidics/nanotechnology research.

Continue reading Siemens Opens Research Facility for Molecular Imaging Biomarkers...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED